Cigna Group (NYSE:CI - Get Free Report) insider Everett Neville sold 1,719 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Cigna Group Trading Down 2.5%
NYSE CI opened at $283.58 on Wednesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a 50-day simple moving average of $280.48 and a 200 day simple moving average of $284.45. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $74.73 billion, a PE ratio of 12.79, a P/E/G ratio of 1.01 and a beta of 0.27.
Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts forecast that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Cigna Group's previous quarterly dividend of $1.51. Cigna Group's dividend payout ratio is currently 27.23%.
Wall Street Analyst Weigh In
A number of research firms have recently commented on CI. The Goldman Sachs Group dropped their price target on Cigna Group from $370.00 to $330.00 and set a "buy" rating on the stock in a research report on Tuesday, November 4th. Wall Street Zen upgraded shares of Cigna Group from a "hold" rating to a "buy" rating in a report on Saturday, February 7th. UBS Group reiterated a "buy" rating and issued a $375.00 price target on shares of Cigna Group in a report on Monday, February 9th. Sanford C. Bernstein restated a "market perform" rating and set a $307.00 price objective on shares of Cigna Group in a report on Tuesday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a "buy" rating in a research report on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $330.42.
View Our Latest Research Report on Cigna Group
Institutional Investors Weigh In On Cigna Group
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in shares of Cigna Group by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock valued at $7,203,754,000 after acquiring an additional 414,834 shares in the last quarter. State Street Corp boosted its holdings in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider's stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock valued at $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox increased its stake in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Finally, Sanders Capital LLC increased its stake in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider's stock worth $2,256,469,000 after purchasing an additional 35,150 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Cigna Group News Summary
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Piper Sandler kept an Overweight rating on CI and cut its price target slightly to $370 (from $374), implying roughly 30% upside from current levels — a vote of confidence from an institutional analyst. Piper Sandler price target story
- Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the succession plan and said Brian Evanko was elected to the board — the reaffirmation reduces immediate earnings guidance risk. PR Newswire release
- Positive Sentiment: Analyst/strategy pieces (e.g., Zacks) continue to highlight Cigna’s growth characteristics and strong fundamentals after recent results, supporting a longer-term constructive view. Zacks analysis
- Neutral Sentiment: Cigna executives (CFO Ann Dennison and Evernorth president Adam Kautzner) presented at the TD Cowen healthcare conference this week — useful for investor Q&A but not a major catalyst. TD Cowen presentation notice
- Neutral Sentiment: Corporate/regional PR (e.g., broker awards in Dubai) highlights distribution/partner relationships but is unlikely to move the stock materially. BusinessWire awards story
- Negative Sentiment: The market reacted negatively to the announced CEO succession: long-time CEO David Cordani will retire July 1, 2026 and become executive chair while President/COO Brian Evanko becomes CEO. Coverage flagged investor concern about leadership change despite Evanko being an internal choice; that concern appears to be the primary near-term reason for the stock decline. Seeking Alpha on leadership transition
Cigna Group Company Profile
(
Get Free Report)
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
